WINSUNBIO
839729
HIGO
872351
DRIVE
838275
4
Shanghai Menon Animal Nutrition Technology
301156
5
Nanjing Railway New Technology
301016
CN Stock MarketDetailed Quotes
002772 Tianshui Zhongxing Bio-technology
- 7.48
- +0.10+1.36%
Market Closed Apr 3 15:00 CST
2.94BMarket Cap22.94P/E (TTM)
7.51High7.33Low65.40KlotVolume7.37Open7.38Pre Close48.72MTurnover1.68%Turnover Ratio22.94P/E (Static)393.24MShares8.8052wk High0.89P/B2.92BFloat Cap5.5252wk Low8.12Limit Up390.14MShs Float30.21Historical High6.64Limit Down2.44%Amplitude5.06Historical Low0.30Dividend TTM7.45Avg Price27.44KlotAsk4.01%Div YieldTTM100Lot Size36.02KlotBid
Tianshui Zhongxing Bio-technology Key Stats
All
YOY
| (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Money funds | 14.71%1.19B | -19.61%1.37B | -27.48%1.24B | -23.09%1.55B | -21.69%1.04B | 26.95%1.7B | 30.53%1.72B | 18.41%2.02B | -16.86%1.33B | -21.29%1.34B |
| Transactional financial assets | 14.20%325.48M | -29.25%266.4M | -31.02%257.2M | -23.90%235.6M | -22.87%285M | -46.02%376.56M | -45.00%372.86M | -12.45%309.58M | 40.27%369.51M | 229.55%697.58M |
| Notes receivable and accounts receivable | 32.37%36.06M | 13.08%31.02M | -16.30%21.44M | -17.91%25.75M | -24.75%27.24M | -11.42%27.43M | -20.62%25.61M | -11.60%31.37M | 102.50%36.2M | 14.45%30.97M |
| -Accounts receivable | 32.37%36.06M | 13.08%31.02M | -16.30%21.44M | -17.91%25.75M | -24.75%27.24M | -11.42%27.43M | -20.62%25.61M | -11.60%31.37M | 102.50%36.2M | 14.45%30.97M |
| Other receivables (including interest and dividends) | 145.37%2.56M | -5.82%2.77M | -16.80%1.88M | 20.88%2.85M | -40.09%1.04M | -4.73%2.94M | -43.04%2.26M | -43.93%2.36M | -53.24%1.74M | -66.51%3.09M |
| -Other receivable | 145.37%2.56M | ---- | -16.80%1.88M | ---- | -40.09%1.04M | ---- | -43.04%2.26M | ---- | -53.24%1.74M | ---- |
| Advance payment | -31.11%22.57M | -24.11%39.61M | -39.75%29.91M | -6.64%39.64M | -23.69%32.77M | 42.32%52.2M | 10.68%49.65M | 71.43%42.46M | 75.86%42.94M | 41.49%36.68M |
| Inventories | -1.75%1.25B | -0.31%1.26B | 0.24%1.26B | 1.02%1.25B | 1.52%1.27B | 4.26%1.26B | 6.95%1.26B | 6.49%1.24B | 6.95%1.26B | 312.75%1.21B |
| Non-current assets due within one year | ---- | ---- | ---- | ---- | ---- | ---- | --4.93M | --4.85M | --4.78M | ---- |
| Total current assets | 6.44%2.83B | -13.35%2.97B | -17.90%2.81B | -14.79%3.11B | -12.44%2.66B | 3.11%3.42B | 5.52%3.43B | 11.00%3.65B | -1.35%3.04B | 46.25%3.32B |
| Non Current assets | ||||||||||
| Debt investment | -11.79%75.97M | -2.35%82M | -5.87%83.86M | 1.14%86.32M | 2.12%86.12M | 4.35%83.97M | 8.96%89.08M | 4.53%85.34M | 3.29%84.33M | -2.82%80.47M |
| Investment real estate | 364.18%82.57M | --37.67M | --38.14M | --17.58M | --17.79M | ---- | ---- | ---- | ---- | ---- |
| Long-term equity investment | 206.44%60.73M | --47.25M | --29.6M | --19.55M | --19.82M | ---- | ---- | ---- | ---- | ---- |
| Long term receivable account | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --4.71M |
| Fixed assets | 2.71%2.51B | ---- | 1.96%2.36B | ---- | 5.28%2.44B | ---- | -4.17%2.31B | ---- | -8.67%2.32B | ---- |
| Fixed assets liquidation | 8,087.75%919.16K | ---- | ---- | ---- | --11.23K | ---- | --274.85 | ---- | ---- | ---- |
| Constru in process | -44.86%276.71M | ---- | -28.64%508.24M | ---- | -33.31%501.84M | ---- | 18.17%712.2M | ---- | 61.28%752.49M | ---- |
| Construction materials | ---- | ---- | -95.12%391.58K | ---- | -68.06%1.24M | ---- | 711.11%8.02M | ---- | 205.62%3.87M | ---- |
| Intangible assets | 2.14%341.52M | -2.51%328.05M | -2.48%330.18M | -2.36%332.27M | -2.34%334.38M | -2.33%336.48M | -2.29%338.59M | -2.35%340.3M | -2.34%342.38M | -2.15%344.51M |
| Long deferred expense | 629.17%350K | 361.31%387.5K | 254.17%425K | -92.31%12K | -75.00%48K | -63.16%84K | -54.55%120K | -48.00%156K | -42.86%192K | -38.71%228K |
| Usufruct assets | -5.97%247.07K | -5.88%250.99K | -5.80%254.91K | -5.71%258.83K | -5.63%262.75K | -5.56%266.67K | -5.48%270.6K | -5.41%274.52K | -5.33%278.44K | --282.36K |
| Other non current assets | 18.51%15.85M | -8.69%10.03M | -9.20%9.97M | -45.66%9.94M | -57.33%13.38M | 53.86%10.99M | 78.39%10.98M | 235.86%18.3M | 62.11%31.35M | -98.60%7.14M |
| Total non current assets | -1.58%3.36B | -2.15%3.34B | -3.25%3.36B | -3.41%3.38B | -3.33%3.41B | -0.97%3.42B | 0.16%3.47B | 1.22%3.5B | 1.71%3.53B | -11.98%3.45B |
| Total assets | 1.93%6.19B | -7.75%6.31B | -10.53%6.17B | -9.22%6.49B | -7.54%6.07B | 1.03%6.84B | 2.75%6.9B | 5.99%7.15B | 0.27%6.57B | 9.37%6.77B |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Short term loan | 98.34%615.46M | 64.18%550M | 36.22%456.33M | 66.15%540M | 106.65%310.3M | 55.81%335M | 55.81%335M | 195.45%325M | 0.10%150.16M | 113.08%215M |
| Notes payable and accounts payable | -33.77%118.6M | -25.26%135.48M | -22.37%142.37M | -8.04%169.17M | -12.82%179.08M | 66.19%181.28M | 85.78%183.39M | 43.22%183.96M | 32.03%205.4M | -9.92%109.08M |
| -Accounts payable | -33.77%118.6M | -25.26%135.48M | -22.37%142.37M | -8.04%169.17M | -12.82%179.08M | 66.19%181.28M | 85.78%183.39M | 43.22%183.96M | 32.03%205.4M | -9.92%109.08M |
| Contract liabilities | -4.63%4.87M | -7.00%6.09M | 28.77%5.24M | 10.58%5.14M | -6.97%5.11M | 23.23%6.55M | 17.23%4.07M | 34.15%4.65M | -17.08%5.49M | 8.41%5.32M |
| Salaries payable | 4.85%103.46M | 17.62%70.81M | 16.09%68.77M | 17.38%67.06M | 23.38%98.68M | 13.15%60.2M | 14.95%59.24M | 15.27%57.13M | 59.95%79.98M | 22.26%53.21M |
| Taxs payable | 27.79%1.3M | 14.49%1.13M | -27.49%2.05M | 4.57%910.72K | 3.06%1.01M | -4.69%983.84K | 189.38%2.83M | -14.55%870.9K | 49.89%984.13K | 91.44%1.03M |
| Other payable (including interest and dividends) | 5.29%175.86M | -2.04%162.78M | -4.15%161.98M | -3.94%164.75M | -2.45%167.03M | -6.57%166.17M | -8.00%168.99M | -7.62%171.51M | -6.99%171.23M | 171.99%177.86M |
| -Other payable | 5.29%175.86M | ---- | -4.15%161.98M | ---- | -2.45%167.03M | ---- | -8.00%168.99M | ---- | -6.99%171.23M | ---- |
| Non current liabilities due within one year | -0.67%694.68M | -57.68%473.84M | -57.83%450.11M | -32.17%648.01M | -15.76%699.38M | 162.80%1.12B | 146.14%1.07B | 13.23%955.34M | 204.59%830.21M | 61.88%426.05M |
| Total current liabilities | 17.37%1.71B | -25.12%1.4B | -29.32%1.29B | -6.09%1.6B | 1.19%1.46B | 89.34%1.87B | 84.48%1.82B | 28.49%1.7B | 76.13%1.44B | 64.72%987.54M |
| Current liabilities | ||||||||||
| Long term loan | -1.40%1.06B | -0.00%1.41B | -3.65%1.44B | -24.26%1.32B | -33.77%1.07B | -26.25%1.41B | -25.40%1.5B | 7.57%1.75B | -16.64%1.62B | 2.44%1.92B |
| Bonds payable | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 4.23%396.46M |
| Long term deferred income | -4.53%98.24M | -15.32%90.61M | -14.47%94.7M | -13.94%98.8M | -13.17%102.9M | -11.73%107.01M | -7.35%110.73M | -7.12%114.8M | -6.82%118.51M | -7.22%121.22M |
| Lease liabilities | -4.31%256.91K | -4.31%253.95K | -4.12%274.79K | -3.96%271.62K | -3.96%268.49K | -11.64%265.4K | -3.47%286.6K | -3.64%282.81K | -3.64%279.55K | --300.37K |
| Total non current liabilities | -1.67%1.16B | -1.08%1.5B | -4.40%1.54B | -23.62%1.42B | -32.36%1.18B | -37.67%1.52B | -36.33%1.61B | -13.43%1.86B | -29.82%1.74B | -0.71%2.44B |
| Total liabilities | 8.87%2.87B | -14.34%2.9B | -17.63%2.83B | -15.26%3.02B | -17.15%2.64B | -1.06%3.39B | -2.41%3.43B | 2.52%3.56B | -3.51%3.18B | 12.12%3.43B |
| Shareholders equity | ||||||||||
| Paid-in capital | 0.00%393.24M | 0.08%393.24M | 0.08%393.24M | -3.49%393.24M | -3.49%393.24M | -3.56%392.93M | -3.56%392.93M | 0.01%407.46M | 0.01%407.46M | -1.26%407.45M |
| Other equity instruments | ---- | ---- | ---- | ---- | ---- | -0.06%87.6M | -0.11%87.6M | -0.08%87.63M | -0.10%87.63M | -0.10%87.65M |
| Capital reserve funds | 0.00%2.02B | 4.66%2.02B | 3.83%2.02B | -0.51%2.02B | -0.44%2.02B | -4.80%1.93B | -4.67%1.95B | -0.35%2.03B | -0.24%2.03B | -1.18%2.03B |
| Surplus reserve funds | 19.83%67.41M | 33.88%56.25M | 33.88%56.25M | 33.88%56.25M | 33.88%56.25M | 20.03%42.02M | 20.03%42.02M | 20.03%42.02M | 20.03%42.02M | 14.09%35.01M |
| Retained profit | -0.11%957.83M | -6.02%929.6M | -13.91%870.43M | -12.03%993.67M | 2.95%958.93M | 10.08%989.11M | 33.02%1.01B | 35.51%1.13B | 13.67%931.46M | 24.83%898.5M |
| Less:Treasury stock | --125.42M | ---- | ---- | ---- | ---- | ---- | -86.34%18.98M | -13.66%120M | -13.66%120M | -31.71%120M |
| Other composite income | 0.00%268.07K | 0.00%268.07K | 0.00%268.07K | 0.00%268.07K | 0.00%268.07K | 0.00%268.07K | 0.00%268.07K | 0.00%268.07K | 0.00%268.07K | 0.00%268.07K |
| Shareholders equity without minority interests | -3.36%3.32B | -1.23%3.4B | -3.47%3.34B | -3.18%3.47B | 1.50%3.43B | 3.16%3.45B | 8.38%3.46B | 9.64%3.58B | 4.09%3.38B | 6.68%3.34B |
| Minority interests | -47.03%1.61M | -42.99%1.95M | -42.02%2.17M | -32.58%2.7M | -0.84%3.04M | 22.62%3.41M | 69.42%3.74M | 57.07%4M | 21.46%3.07M | 10.90%2.78M |
| Total shareholder equity | -3.40%3.32B | -1.28%3.41B | -3.51%3.35B | -3.21%3.47B | 1.50%3.44B | 3.18%3.45B | 8.42%3.47B | 9.68%3.59B | 4.11%3.38B | 6.69%3.34B |
| Total liabilityies and equity | 1.93%6.19B | -7.75%6.31B | -10.53%6.17B | -9.22%6.49B | -7.54%6.07B | 1.03%6.84B | 2.75%6.9B | 5.99%7.15B | 0.27%6.57B | 9.37%6.77B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- |
| Auditor | China Audit Zhonghuan Certified Public Accountants Co., Ltd. (Special General Partnership) | -- | -- | -- | China Audit Zhonghuan Certified Public Accountants Co., Ltd. (Special General Partnership) | -- | -- | -- | China Audit Zhonghuan Certified Public Accountants Co., Ltd. (Special General Partnership) | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.